218 related articles for article (PubMed ID: 17581351)
41. Enteroviral infection in patients treated with rituximab for non-Hodgkin lymphoma: a case series and review of the literature.
Grisariu S; Vaxman I; Gatt M; Elias S; Avni B; Arad A; Pasvolsky O; Raanani P; Paltiel O
Hematol Oncol; 2017 Dec; 35(4):591-598. PubMed ID: 27734521
[TBL] [Abstract][Full Text] [Related]
42. A case of primary cardiac lymphoma: analysis of the role of echocardiography in early diagnosis.
Faganello G; Belham M; Thaman R; Blundell J; Eller T; Wilde P
Echocardiography; 2007 Sep; 24(8):889-92. PubMed ID: 17767544
[TBL] [Abstract][Full Text] [Related]
43. Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.
Johnston KL; Farnen JP; Manske BR; Go RS
Haematologica; 2005 Dec; 90(12 Suppl):EIM03. PubMed ID: 16464762
[No Abstract] [Full Text] [Related]
44. Presentation of Diffuse Large B-Cell Lymphoma Relapse as a Penile Mass.
Öneç B; Öneç K; Esbah AÜ; Esbah O
Turk J Haematol; 2016 Dec; 33(4):362-363. PubMed ID: 27095140
[No Abstract] [Full Text] [Related]
45. Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas.
Hagemeister F; Rodriguez MA; Deitcher SR; Younes A; Fayad L; Goy A; Dang NH; Forman A; McLaughlin P; Medeiros LJ; Pro B; Romaguera J; Samaniego F; Silverman JA; Sarris A; Cabanillas F
Br J Haematol; 2013 Sep; 162(5):631-8. PubMed ID: 23802738
[TBL] [Abstract][Full Text] [Related]
46. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma.
Spina M; Simonelli C; Tirelli U
J Clin Oncol; 2007 Feb; 25(6):e7. PubMed ID: 17308261
[No Abstract] [Full Text] [Related]
47. A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
Sinha R; Kaufman JL; Khoury HJ; King N; Shenoy PJ; Lewis C; Bumpers K; Hutchison-Rzepka A; Tighiouart M; Heffner LT; Lechowicz MJ; Lonial S; Flowers CR
Cancer; 2012 Jul; 118(14):3538-48. PubMed ID: 22535574
[TBL] [Abstract][Full Text] [Related]
48. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
Yuan ZY; Xu RH; He YJ; Guan ZZ
Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996
[TBL] [Abstract][Full Text] [Related]
49. Relapsed non-Hodgkin lymphoma in fraternal twins managed successfully with rituximab maintenance therapy.
Chakravarti A; Leslie WT; Venugopal P
Clin Adv Hematol Oncol; 2005 Feb; 3(2):136-9; discussion 139-40. PubMed ID: 16166983
[No Abstract] [Full Text] [Related]
50. Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma.
Kikuchi M; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kako S; Kanda J; Nishida J; Sekiguchi N; Noto S; Kida M; Hangaishi A; Usuki K; Kanda Y
J Chemother; 2015 Feb; 27(2):99-105. PubMed ID: 25314911
[TBL] [Abstract][Full Text] [Related]
51. [Treatment strategy of high malignancy non-Hodgkin lymphomas].
Pfreundschuh M; Trümper L
Praxis (Bern 1994); 1998 Jun; 87(23):812-5. PubMed ID: 9654988
[TBL] [Abstract][Full Text] [Related]
52. Progressive Multifocal Leukoencephalopathy Following Treatment with Rituximab in an HIV-Negative Patient with Non-Hodgkin Lymphoma. A Case Report and Literature Review.
Felli V; Di Sibio A; Anselmi M; Gennarelli A; Sucapane P; Splendiani A; Catalucci A; Marini C; Gallucci M
Neuroradiol J; 2014 Dec; 27(6):657-64. PubMed ID: 25489887
[TBL] [Abstract][Full Text] [Related]
53. Community-based trial of R-CHOP and maintenance rituximab for intermediate- or high-grade non-Hodgkin lymphoma with first-cycle filgrastim for older patients.
Case DC; Desch CE; Kalman LA; Vongkovit P; Mena RR; Fridman M; Allen B
Clin Lymphoma Myeloma; 2007 Mar; 7(5):354-60. PubMed ID: 17562245
[TBL] [Abstract][Full Text] [Related]
54. Remission of follicular non-Hodgkin's lymphoma with denileukin diftitox (ONTAK) after progression during rituximab, CHOP and fludarabine therapy.
Paschal BR
Leuk Lymphoma; 2003 Apr; 44(4):731-3. PubMed ID: 12769354
[TBL] [Abstract][Full Text] [Related]
55. High efficacy of the CHOP + rituximab association in a case of primary rectal non-Hodgkin lymphoma (NHL).
Vassallo E; Di Noto L; Palmeri L; Vaglica M; Pancera G; Palmeri S
Leuk Lymphoma; 2006 Aug; 47(8):1686-7. PubMed ID: 16966287
[No Abstract] [Full Text] [Related]
56. Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab.
Zell JA; Yoon EJ; Ignatius Ou SH; Hoefs JC; Chang JC
Anticancer Drugs; 2005 Jan; 16(1):83-5. PubMed ID: 15613909
[TBL] [Abstract][Full Text] [Related]
57. Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge.
Skrabs C; Müller C; Agis H; Mannhalter C; Jäger U
Leukemia; 2002 Sep; 16(9):1884-6. PubMed ID: 12200717
[No Abstract] [Full Text] [Related]
58. Pre-existing arterial hypertension as a risk factor for early left ventricular systolic dysfunction following (R)-CHOP chemotherapy in patients with lymphoma.
Szmit S; Jurczak W; Zaucha JM; Drozd-Sokołowska J; Spychałowicz W; Joks M; Długosz-Danecka M; Torbicki A
J Am Soc Hypertens; 2014 Nov; 8(11):791-9. PubMed ID: 25455004
[TBL] [Abstract][Full Text] [Related]
59. Breast lymphoma.
Avilés A
Ann Oncol; 2008 Jul; 19(7):1360. PubMed ID: 18579558
[No Abstract] [Full Text] [Related]
60. Chemoradiotherapy for localized non-Hodgkin's lymphoma.
Cosset JM
N Engl J Med; 1998 Jul; 339(1):44-5. PubMed ID: 9647881
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
